P9R is a cationic peptide featuring arginine-rich segments that enhance nucleic-acid binding and membrane affinity. The sequence supports structured folding in lipidic or aqueous environments. Researchers investigate its translocation propensity and electrostatic interactions. Applications include CPP-like mechanism studies, nucleic-acid binding models, and peptide-design optimization.
CAT No: R2811
P9R, a synthetic carbohydrate compound, represents a significant advancement in the field of glycoscience and molecular research. Engineered to mimic specific carbohydrate motifs, P9R exhibits unique binding properties and structural stability, making it a valuable tool for diverse scientific investigations. Its design facilitates interactions with a range of biological molecules, enabling researchers to explore carbohydrate-mediated processes with precision. The compound's versatility extends to both in vitro and in vivo experimental systems, supporting its integration into a variety of research workflows. With its robust chemical architecture, P9R stands out as a preferred reagent for studies requiring reliable carbohydrate analogs.
Glycan-Protein Interaction Studies: P9R is widely utilized in the elucidation of glycan-protein interactions, a cornerstone of understanding cellular communication and recognition. By serving as a model ligand, it enables the mapping of carbohydrate recognition domains on lectins and other glycan-binding proteins. Researchers employ the compound in binding assays, surface plasmon resonance, and microarray formats to delineate the specificity and affinity of protein-carbohydrate interactions. These insights are critical for deciphering mechanisms underlying cell signaling, adhesion, and immune modulation. The use of P9R in these applications accelerates the identification of novel therapeutic targets and enhances our comprehension of complex biomolecular networks.
Pathogen Adhesion Inhibition: In the realm of infectious disease research, P9R offers a powerful approach to studying pathogen-host interactions. Many pathogens exploit specific carbohydrate motifs on host cell surfaces to initiate infection. The compound can competitively inhibit these adhesion events by mimicking natural glycan structures, thereby serving as a decoy in experimental settings. This property is particularly valuable in the screening of anti-adhesive agents and in the investigation of microbial colonization mechanisms. By incorporating P9R into cell culture or tissue models, scientists can dissect the molecular determinants of pathogen binding and identify strategies to disrupt infection pathways at the earliest stages.
Enzyme Substrate Analysis: The compound also plays a pivotal role in the characterization of carbohydrate-active enzymes such as glycosidases and glycosyltransferases. As a structurally defined substrate, P9R enables precise measurement of enzyme activity, substrate specificity, and kinetic parameters. Researchers leverage it in high-throughput screening platforms to discover enzyme inhibitors or activators, which are essential for probing metabolic pathways and developing novel biocatalysts. The reproducibility and consistency offered by P9R contribute to the generation of reliable enzymological data, supporting both fundamental research and applied biotechnology initiatives.
Vaccine Research and Antigen Design: P9R's ability to mimic pathogen-associated carbohydrate patterns makes it a valuable component in vaccine research and synthetic antigen development. By presenting defined glycan epitopes, it aids in the study of immune recognition and the design of carbohydrate-based immunogens. Scientists use the compound to investigate antibody specificity and to optimize antigenic formulations for enhanced immunogenicity in preclinical models. Its application in this context advances the rational design of next-generation vaccines that target carbohydrate antigens, broadening the scope of preventive strategies against infectious agents.
Diagnostic Assay Development: In the field of diagnostic technology, P9R is incorporated into assay platforms for the detection of glycan-binding proteins, antibodies, or pathogens. Its structural fidelity ensures high specificity and sensitivity in immunoassays, biosensors, and affinity chromatography systems. The compound's compatibility with various detection modalities, such as fluorescence or electrochemical readouts, supports its use in both qualitative and quantitative analyses. By facilitating the reliable identification of disease biomarkers or infectious agents, P9R contributes to the development of advanced diagnostic tools that enhance disease monitoring and research capabilities.
2. An Open-label, Single-center, Safety and Efficacy Study of Eyelash Polygrowth Factor Serum
4. The spatiotemporal control of signalling and trafficking of the GLP-1R
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More